Chinese Center for Disease Control and Prevention · Full chronicle and history

According to sentinel surveillance data from the Chinese Center for Disease Control and Prevention, in the 29th week of 2026 (July 13 to 19), the COVID-19 test positivity rate in China surpassed that of influenza, remaining the leading respiratory pathogen for several consecutive weeks.

The international medical journal The Lancet published a research report jointly completed by the Chinese Center for Disease Control and Prevention and Beijing Anding Hospital, estimating that the number of people with mental disorders in China reached 190 million in 2023, an increase of about 45.6% compared with 1990, including 59.6 million patients with depressive disorders and 58.7 million patients with anxiety disorders.

On August 13, 2026, the Chinese Center for Disease Control and Prevention reported 522,000 new confirmed COVID-19 cases nationwide in July, including 487 severe cases and 1 death, 6.6 times the figure for June.

China's Center for Disease Control and Prevention released monitoring data showing that the positivity rate of COVID-19 tests rose from July 20 to July 26, up 4 percentage points compared with the previous week, with the dominant strain being NB.1.8.1.

On July 30, 2026, the Chinese Center for Disease Control and Prevention released surveillance data showing that the positivity rate for COVID-19 among influenza-like cases in outpatient and emergency departments of sentinel hospitals nationwide climbed to 20.3%, with fever clinic patients increasing significantly in Guangdong, Henan and many other places.